Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1983-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JAC/12.4.407PMID 6643335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis

  1983cited by this paper
• Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency

  1981cited by this paper
• Single-dose pharmacokinetics of cefoperazone following intravenous administration.

  1980cited by this paper

• Schistosomiasis, a common parasitic disease, can change the pharmacokinetics of certain drugs, thereby affecting clinical outcomes

  2014cites this paper
• Schistosomiasis, a common parasitic disease, can change the pharmacokinetics of certain drugs, thereby affecting clinical outcomes

  2014cites this paper
• A Review of the Pharmacokinetic Implications of Schistosomiasis

  2013cites this paper
• Penetration of cefoperazone into ascites

  2004cites this paper
• Prescribing for patients with liver disease.

  1989cites this paper
• Altered drug metabolism in parasitic diseases.

  1988cites this paper
• Clinical Pharmacokinetics of the Third Generation Cephalosporins

  1985cites this paper